The Director Of Medtronic plc (MDT) Purchased 6,835 Shares

BEPC Stock
BEPC Stock

As of Thursday close, Medtronic plc’s (NYSE:MDT) stock was down -$3.95, moving down -4.51 percent to $83.54. The average number of shares traded per day over the past five days has been 7,193,640 shares. 2 times new highs have been achieved over the past 5 days, with a -$5.48 fall in that time frame. In the last twenty days, the average volume was 5,382,680, while in the previous 50 days, it was 5,948,630.

Since last month, MDT stock retreated -7.15%. Shares of the company fell to $82.31 on 05/25/23, the lowest level in the past month. A 52-week high of $106.06 was reached on 05/03/23 after having rallying from a 52-week low of $75.76. Since the beginning of this year, MDT’s stock price has risen by 7.49% or $5.82, and marked a new high 13 times. However, the stock has declined by -21.23% since its 52-week high.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


MDT stock investors should be aware that Medtronic plc (MDT) stock had its last reported insider trading activity 116 days ago on Jan 30. Medtronic plc, the 10% Owner of the company, purchased of 6,835 shares for $9.28 on Jan 30. It resulted in a $63,436 investment by the insider. Salmon Sean sold 16,631 shares at an average price of $80.50 on Dec 13. The insider now owns 36,088 shares following the transaction. On Oct 14, EVP and Pres. Global Regions TEN HOEDT ROB sold 2,404 shares at $81.54 apiece. The transaction was valued at $196,015.

Valuation Metrics

Right now, Medtronic plc (MDT) has a P/E ratio of about 27.46. The stock’s beta is 0.72. Besides these, the trailing price-to-sales (P/S) ratio of 3.60, the price-to-book (PB) ratio of 2.16, and the price-to-cash flow ratio of 180.68 may also be considered.

The latest dividend of $0.69 per share was paid out, which is 1.47% more than last year’s $0.68.

Financial Health

In the three months ended January 30, Medtronic plc’s quick ratio stood at 1.40, while its current ratio was 1.80, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending January 30 was 0.43, and the total debt-to-equity ratio was 0.55. On the profitability front, the trailing twelve-month gross margin is 66.70% percent. In the year ended January 30, EBITDA margin amounted to 28.07%, whereas operating margins totaled 18.00%. Based on annual data, MDT earned $21.54 billion in gross profit and brought in $31.69 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 6.90%. Return on equity (ROE) for the past 12 months was 7.80%.

In Medtronic plc’s quarter-end financial report for January 30, it reported total debt of $22.21 billion against cash and short-term investments of $6.62 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. MDT’s revenue fell -0.47% to $7.58 billion during the quarter, while net income inched up to $7.73 billion. While analysts expected Medtronic plc to report $1.27 quarterly earnings, the actual figure was $1.3 per share, beating the consensus estimate by 2.40%. During the quarter, the company generated $2.07 billion in EBITDA. The liabilities of Medtronic plc were 42.52 billion at the end of its most recent quarter ended January 30, and its total debt was $28.13 billion. The value of shareholders’ equity is $1.33 billion.

Technical Picture

This quick technical analysis looks at Medtronic plc’s (MDT) price momentum. With a historical volatility rate of 26.08%, the RSI 9-day stood at 23.34% on 25 May.

With respect to its five-day moving average, the current Medtronic plc price is down by -6.16% percent or -$5.48. At present, MDT shares trade -8.58% below its 20-day simple moving average and +7.49% percent above its 100-day simple moving average. However, the stock is currently trading approximately +6.54% above its SMA50 and -10.27% below its SMA200.

Stochastic coefficient K was 12.87% and Stochastic coefficient D was 20.05%, while ATR was 1.75. Given the Stochastic reading of 15.20% for the 14-day period, the RSI (14) reading has been calculated as 34.02%. As of today, the MACD Oscillator reading stands at -2.04, while the 14-day reading stands at -2.51.

Analyst Ratings

Medtronic plc (MDT) has been rated Overweight by analysts. According to 2 brokerage firms, MDT is a sell, and 14 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 5 analysts rate Medtronic plc stock as buy, with 9 recommending it as overweight.

With a median target price of $90.00, the current consensus forecast for the stock is $77.00 – $104.00. Based on these forecasts, analysts predict Medtronic plc (MDT) will achieve an average price target of $91.00.


Please enter your comment!
Please enter your name here